Startups
Stock Connect Success: How Harbour BioMed’s Listing Signals a New Era of Cross-Border Capital Flow
Harbour BioMed's inclusion in the Stock Connect validates the maturity and increasing reliability of regulated cross-border capital channels between mainland China and Hong Kong, setting a precedent for other global listing types.
Mon, 07 Sep 2026